DEBORAH SCALLY: Open Payments
NPI 1831634625 · HURON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 48 payments from 15 companies in 2025. Trend: 2023 $846 · 2024 $732 · 2025 $933
Food & beverage: $890Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $236 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $158 |
| Abbott Laboratories | 4 | $82 |
| Xeris Pharmaceuticals, Inc. | 4 | $76 |
| Novo Nordisk Inc | 5 | $75 |
| Mannkind Corporation | 2 | $60 |
| BETA BIONICS, INC. | 2 | $45 |
| Tandem Diabetes Care, Inc. | 3 | $43 |
| Dexcom, Inc. | 2 | $36 |
| Insulet Corporation | 1 | $25 |
Products named: ISTURISA, MOUNJARO, FREESTYLE LIBRE 3, GVOKE HYPOPEN, AFREZZA, iLet Bionic Pancreas, Ozempic, JARDIANCE.
Industry payments across OH — which companies pay providers there.
